that assesses gene function and approves new allele designations. To allow the database to reflect the content of the live repositories to within a useful time frame, any regular automated updates of the reference database from live repositories could label new alleles with 'provisional' designations prior to committee approval. As a method for identifying resistance genes from WGS data the use of a reference pseudomolecule/database may yet be superseded, but the above model is attractive for use against highly clinically relevant factors including metallo-carbapenemases and other antimicrobial resistance factors. 
Sir, Previously, we studied a collection of extensively antibioticresistant Acinetobacter baumannii belonging to global clone 2 (GC2) from Australian hospitals in Sydney, Brisbane and Canberra.
1 These 61 closely related carbapenem-resistant isolates shared a common set of resistance genes, but were subdivided into five different groups based on their aminoglycoside resistance phenotypes. One group harboured aacC1 (gentamicin resistance), aphA1 in Tn6020 (kanamycin and neomycin resistance) and aphA6 in TnaphA6 (amikacin, kanamycin and neomycin resistance). We subsequently showed that aacC1 and aphA1 were located in a chromosomal resistance island, AbGRI2-1, in two representatives of this collection that did not carry TnaphA6. 2 The aphA6 gene was originally recovered from an A. baumannii isolate on a 63 kb plasmid that was transferrable to other Acinetobacter spp. 3 However, this plasmid was not sequenced. Recently, TnaphA6 was found on a completely sequenced 70 kb conjugative plasmid, pAb-G7-2 (GenBank accession number KF669606), 4 which was in a GC1 isolate from Melbourne. pAb-G7-2 belongs to the repAci6 plasmid family. 4 The archetype of the repAci6 family, 5 pACICU2, was originally reported to be cryptic. 6 However, it was recently shown to carry TnaphA6 in the same position as pAb-G7-2 and to transfer amikacin resistance. 7 Here, we have examined whether the TnaphA6 in the GC2 isolates, D72 and C20, which also harbour aacC1 and aphA1, may also be on a conjugative repAci6 family plasmid. While D72 and C20 had the same resistance phenotype and gene content, To determine whether C20 and D72 harboured pAb-G7-2, the PCR mapping strategy described previously was used. 4 For C20, all of the PCRs produced amplicons identical to those in pAb-G7-2, indicating that C20 contained a plasmid with TnaphA6 in the same position. A draft genome sequence for C20 was # The Author 2014. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com subsequently generated at the Wellcome Trust Sanger Institute using Illumina HiSeq. 8 A standalone BLAST 9 search using pAb-G7-2 as a query retrieved a 68 kb contig that matched pAb-G7-2 and a contig containing most of TnaphA6. The assembled repAci6 plasmid in C20 was identical to pAb-G7-2.
In D72, the plasmid backbone was present, but was not interrupted at the TnaphA6 position in pAb-G7-2, and this was confirmed using the draft genome sequence of D72 (Figure 1) . However, two plasmid backbone contigs ended with a fragment of ISAba125, which flanks aphA6 in TnaphA6. Primers adjacent to the ISAba125 pieces, RH1319 (TTCCATTGCATCGTTTGAGA) and RH1320 (TTTACGATAATTGCATGGATGT), amplified a 3.3 kb product, indicating that TnaphA6 was at a different position relative to that in pAb-G7-2 ( Figure 1 ). PCRs linking RH1319 and RH1320 to aphA6 produced amplicons of the size predicted if TnaphA6 was present at this second location. The complete sequence of a 70 102 bp plasmid in D72 was assembled as described previously 4 for pAb-G7-2 ( Figure 1 ) and was deposited into GenBank under the accession number KM051846. This plasmid was named pD72-2.
The backbones of pD72-2 and pAb-G7-2 shared 99.9% sequence identity. There were 61 nucleotide differences, four single-base gaps and one two-base gap in pD72-2. There was a single nucleotide difference between the repAci6 genes that resulted in a single amino acid change (L344I) and a single additional base in the third of the three previously defined repeat regions 4 (3 in Figure 1 ). Comparison of pD72-2 with pA85, 10 a closely related repAci6 plasmid that does not contain TnaphA6, but harbours bla OXA-23 in AbaR4, showed that the pD72-2 backbone was smaller, suggesting that there are a number of separate sublineages in the repAci6 plasmid family.
Both D72 and C20 also included a small 10 967 bp cryptic repAci2 plasmid that carries a mobilization gene and a single ISAba125. This plasmid was named pD72-1 (GenBank accession number KM051986). C20 harboured a second 110967 bp cryptic plasmid that shared 99.99% identity (six single-base changes) with pABTJ2 (GenBank accession number CP004359). The rep gene of pABTJ2 did not fit within one of the previously defined A. baumannii rep families, 5 and its Rep protein of 373 amino acids shared only 41% amino acid identity with a 218 amino acid segment of RepAci2 (316 amino acids).
Assembly of contigs in the draft genomes of C20 and D72 using PCR showed that they both contained AbGRI2. C20 harboured an island identical to AbGRI2-1, which has aacC1 and aphA1, while D72 had a variant of AbGRI2-1 with at least one additional copy of aphA1. Both C20 and D72 also had a chromosomal resistance island in comM that was identical to Tn6167, 11 here renamed AbGRI1-2. The bla OXA-23 gene, conferring resistance to carbapenems, is within Tn2006 in AbGRI1-2.
This study shows that TnaphA6 has been acquired by almost identical repAci6 plasmids on at least two separate occasions. Screening for the position of TnaphA6 in these plasmids should be a valuable epidemiological tool and aid in tracking the spread of these conjugative resistance plasmids. 
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